HL-60 In Vitro Protein Expression Analysis Assay (Immunoassays)
CAT#: ITS-1122-YF3767
Target Cell Organism: Human
Target Cell Alternative Name: HL60
Target Cell Name: HL-60
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide HL-60-based In Vitro Protein Expression Analysis Assay (Immunoassays) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HL-60
Target Cell Organism
Human
Target Cell Background
The HL-60 cell line is a human leukemia cell line that has been used for laboratory research on blood cell formation and physiology. HL-60 proliferates continuously in suspension culture in nutrient and antibiotic chemicals. The doubling time is about 36-48 hours. The cell line was derived from a 36-year-old woman who was originally reported to have acute promyelocytic leukemia at the MD Anderson Cancer Center.
Target Cell Alternative Name
HL60
Related Diseases
Leukemia
Research Area
Oncology
Assay Name
In Vitro Protein Expression Analysis Assay (Immunoassays)
Short Description
HL-60-cell based In Vitro Protein Expression Analysis Assay (Immunoassays)
Assay Description
For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.